Lusíadas, SGPS, S.A. has signed a contract to acquire Clínicas Dr. Wells from Sonae, SGPS, S.A. (ENXTLS:SON) on November 3, 2023. The transaction is still subject to prior approval by the Competition Authority and the group expects a decision during the first quarter of 2024.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.969 EUR | +1.47% | +3.09% | +7.13% |
17/04 | Sonae Unit Closes Purchase of Majority Stake in BCF Life Sciences-owner Diorren | MT |
19/03 | Sonae Issues EUR150 Million Bonds | MT |
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+7.13% | 2.01B | |
-8.81% | 39.14B | |
+18.33% | 37.47B | |
+8.23% | 33.09B | |
+5.62% | 19.62B | |
+1.06% | 14.3B | |
-14.54% | 13.3B | |
+19.35% | 12.14B | |
-.--% | 11.82B | |
-3.05% | 11.93B |
- Stock Market
- Equities
- SON Stock
- News Sonae - SGPS, SA
- Lusíadas, SGPS, S.A. has signed a contract to acquire Clínicas Dr. Wells from Sonae, SGPS, S.A..